Apollo Hospitals offers 5 lakh Covaxin doses to government - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Atishi requests Central govt. to make more doses available
Aam Aadmi Party (AAP) leader Atishi on Thursday said the Capital was left with just two to three days’ stock of COVID-19 vaccine doses for those above 45 years of age as well as engaged in healthcare and front-line duties.
For those falling in the 18-44 age group, she said, Delhi had eight days’ stock of Covishield doses available. Over 41 lakh doses had been administered in the city so far and 74,448 people having been vaccinated in Delhi on Wednesday, she said.
“Delhi currently has three days of Covaxin and two days of Covishield stock for those above 45 years of age, healthcare and front-line workers. We request the government to make more doses available for this category,” she said.
An indemnity bond, effectively, offers legal protection to a manufacturer in case a vaccine causes adverse events. A frontline worker receives her first dose of the COVID-19 vaccine. | Photo Credit: PTI
Key Highlights
Pfizer was one of the first manufacturers to apply for emergency-use authorisation (EUA) for its vaccine in India, but was forced to withdraw its application following the central government s insistence that it conduct bridging trials in the country
In response to an RTI application, the central government stated that there was no proposal being considered to indemnify or exempt vaccine manufacturers from liability borne out adverse events caused via inoculation
JJ Hospital
MUMBAI: In a twist to the Covaxin story, eight doctors from the Mumbai region rejected the Serum Institute’s Covishield vaccine and took shots of Covaxin instead at JJ Hospital on Wednesday.
Hospital authorities, who have struggled to persuade potential recipients to accept Covaxin, were enthused by the incident. They said they will henceforth allow voluntary walk-ins for the Bharat Biotech-manufactured vaccine so long as names are registered on the Co-Win app which is used to monitor the immunisation programme. The arrangement, though, is a one-way street for now – such flexibility is not on offer for those allotted Covaxin but show preference for Covishield.